Publications

Detailed Information

The Role of Indoleamine 2,3-Dioxygenase in Retinal Pigment Epithelial Cell-mediated Immune Modulation

DC Field Value Language
dc.contributor.authorPark, Choul Yong-
dc.contributor.authorYang, Seung-Ha-
dc.contributor.authorChuck, Roy S.-
dc.contributor.authorGehlbach, Peter L.-
dc.contributor.authorPark, Chung-Gyu-
dc.date.accessioned2012-06-11T02:14:52Z-
dc.date.available2012-06-11T02:14:52Z-
dc.date.issued2010-01-
dc.identifier.citationOCULAR IMMUNOLOGY AND INFLAMMATION; Vol.18 1; 24-31ko_KR
dc.identifier.issn0927-3948-
dc.identifier.urihttps://hdl.handle.net/10371/76944-
dc.description.abstractPurpose: To evaluate the role of indoleamine dioxygenase (IDO) in human retinal pigment epithelial cell (RPE)-mediated immune modulation. Methods: The immunosuppression of cultured human RPEs (ARPE-19 cells) was assayed using the mixed lymphocyte reaction (MLR) harvested from CBA/J and BALB/c mice. The expression of critical immune modulatory molecules, such as class II major histocompatibility complex (MHC) molecules, co-stimulatory molecules (B7-1 and B7-2), and indoleamine dioxygenase (IDO), was examined by reverse transcriptase polymerase chain reaction, flow cytometry, and immunofluorescence staining with and without IFN-gamma stimulation. Results: RPEs expressed IDO and class II MHC molecules under IFN-gamma stimulation. However, B7-1 and B7-2 were not expressed. RPE significantly suppressed MLR in the absence of IFN-gamma prestimulation. This phenomenon was enhanced by IFN-gamma stimulation. The addition of 1-methyl tryptophan l into the culture medium successfully reversed RPE immunosuppression. Conclusions: The expression of IDO may in part explain RPE-mediated immune suppression effects.ko_KR
dc.language.isoenko_KR
dc.publisherInforma Healthcareko_KR
dc.subjectco-stimulatory moleculeko_KR
dc.subject3-dioxygenaseko_KR
dc.subjectmajor histocompatibility complexko_KR
dc.subjectIndoleamine 2ko_KR
dc.subjectImmune modulationko_KR
dc.subjectretinal pigment epitheliumko_KR
dc.titleThe Role of Indoleamine 2,3-Dioxygenase in Retinal Pigment Epithelial Cell-mediated Immune Modulationko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor박철용-
dc.contributor.AlternativeAuthor양승하-
dc.contributor.AlternativeAuthor박청규-
dc.identifier.doi10.3109/09273940903326203-
dc.citation.journaltitleOCULAR IMMUNOLOGY AND INFLAMMATION-
dc.description.citedreferenceSugita S, 2008, J IMMUNOL, V181, P7525-
dc.description.citedreferenceUsui Y, 2008, EXP EYE RES, V86, P52, DOI 10.1016/j.exer.2007.09.007-
dc.description.citedreferenceGregerson DS, 2007, INVEST OPHTH VIS SCI, V48, P4654, DOI 10.1167/iovs.07-0286-
dc.description.citedreferenceSugita S, 2006, EXP EYE RES, V83, P1459, DOI 10.1016/j.exer.2006.08.005-
dc.description.citedreferenceZamiri P, 2006, INVEST OPHTH VIS SCI, V47, P3912, DOI 10.1167/iovs.05-1267-
dc.description.citedreferenceAgaugue S, 2006, J IMMUNOL, V177, P2061-
dc.description.citedreferenceKaestel CG, 2005, CURR EYE RES, V30, P375-
dc.description.citedreferenceZamiri P, 2005, INVEST OPHTH VIS SCI, V46, P908, DOI 10.1167/iovs.04-0362-
dc.description.citedreferenceMunn DH, 2004, J IMMUNOL, V172, P4100-
dc.description.citedreferenceSugita S, 2004, J IMMUNOL, V172, P4184-
dc.description.citedreferenceStreilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224-
dc.description.citedreferenceSun DM, 2003, J NEUROIMMUNOL, V144, P1, DOI 10.1016/S0165-5728(03)00248-0-
dc.description.citedreferenceSugita S, 2003, J EXP MED, V198, P161, DOI 10.1084/jem.20030097-
dc.description.citedreferenceIshida K, 2003, OCUL IMMUNOL INFLAMM, V11, P91-
dc.description.citedreferenceGrohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3-
dc.description.citedreferenceMomma Y, 2003, INVEST OPHTH VIS SCI, V44, P2026, DOI 10.1167/iovs.02-0980-
dc.description.citedreferenceFrumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121-
dc.description.citedreferenceStreilein JW, 2002, HUM IMMUNOL, V63, P435-
dc.description.citedreferenceStreilein JW, 2002, DNA CELL BIOL, V21, P453-
dc.description.citedreferenceKanuga N, 2002, INVEST OPHTH VIS SCI, V43, P546-
dc.description.citedreferenceJorgensen A, 2001, EXP EYE RES, V73, P723, DOI 10.1006/exer.2001.1082-
dc.description.citedreferenceWolfram RM, 2000, INT J CANCER, V88, P239-
dc.description.citedreferenceWenkel H, 2000, INVEST OPHTH VIS SCI, V41, P3467-
dc.description.citedreferenceBabcock TA, 2000, CYTOKINE, V12, P588-
dc.description.citedreferenceHollborn M, 2000, CURR EYE RES, V20, P488-
dc.description.citedreferenceFarrokh-Siar L, 1999, GRAEF ARCH CLIN EXP, V237, P934-
dc.description.citedreferenceMellor AL, 1999, IMMUNOL TODAY, V20, P469-
dc.description.citedreferenceEnzmann V, 1999, OPHTHALMIC RES, V31, P256-
dc.description.citedreferenceMunn DH, 1999, J EXP MED, V189, P1363-
dc.description.citedreferenceBodaghi B, 1999, J IMMUNOL, V162, P957-
dc.description.citedreferenceHoltkamp GM, 1999, EUR J IMMUNOL, V29, P215-
dc.description.citedreferenceNagineni CN, 1996, INFECT IMMUN, V64, P4188-
dc.description.citedreferenceNagineni CN, 1996, CYTOKINE, V8, P622-
dc.description.citedreferenceDevine L, 1996, IMMUNOLOGY, V88, P456-
dc.description.citedreferenceMalina HZ, 1996, GRAEF ARCH CLIN EXP, V234, P457-
dc.description.citedreferencePLATTS KE, 1995, INVEST OPHTH VIS SCI, V36, P2262-
dc.description.citedreferenceLIVERSIDGE J, 1993, CELL IMMUNOL, V149, P315-
dc.description.citedreferenceLIVERSIDGE JM, 1988, CLIN EXP IMMUNOL, V73, P489-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share